2. Fluid Management in Dengue Hemorrhagic Fever

Slides:



Advertisements
Similar presentations
Fundamentals of Pharmacology for Veterinary Technicians
Advertisements

Emergency Care Part 1: Managing Diabetic Ketoacidosis (DKA)
Prescribing IV Infusions
Coagulopathy and blood component transfusion in trauma
IV infusions Calculating volume of fluid delivered over time:
Anesthetic Implications In Neonates & Children: Intravenous fluids
Fluids: an e-Learning resource
IV Fluid Management DFM Fellows Summer 2010.
Dengue Expert Advisory Group
Administration of Blood and Blood Products PN 3 November 2005.
Phase 2; Year 2; G-I Block Acute Patient Assessment Acute Care Theme Topic Prof J A W Wildsmith.
JAHD – 1/5/2012 PETER COTTRELL Estimation of ‘Burn % Total Body Surface Area (TBSA)’ and fluid resuscitation.
Dr Bronwyn Avard, July 2010  To understand the basic physiology of shock  To understand the pharmacodynamics and pharmacokinetics of vasoactive drugs.
Fluids and Electrolyte Balance There is daily fluid intake and fluid out put *fluid intake: Its from two main sources 1-Exogenous Water is either drunk.
Principals of fluids and electrolytes management
Development Committee
Topic 3 Math/Drugs Calculations. IV Giving Sets Generally there are 2 types of giving sets in use and they deliver drops of different sizes Blood giving.
2 Module 1 Pathophysiology Clinical course WHO classification & limitation Other manifestations Dr Suresh Kumar Infectious Diseases Unit Hospital Sungai.
SEPSIS KILLS program Adult Inpatients
Nadin Abdel Razeq, PhD. Objectives To gain awareness of the proper procedure of peripheral IV access in pediatrics To review types of IV fluids used in.
CHAPTER 2 Part 2. PATIENT PREPARATION IV CATHETERS: catheters are ideal for all anesthetic procedures Can provide IV fluids for support during surgery.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U.
Recognition and management of the seriously ill child Dr Esyld Watson Consultant in Adult and Paediatric Emergency Medicine.
PERIOPERATIVE FLUID THERAPY
Management of Dengue Fever Dr David Tran 16/09/09.
Cardiovascular Emergencies
Illinois EMSC1 Upon completion of this lecture, you will be better able to: n Define shock n Describe key differences between the pediatric and adult circulatory.
Case Study: Dengue Virus Virology 516 Fall 2007 Milette Mahinan, Suzi Sanchez, Olayinka Taiwo.
Shock.
3. Documentation and Monitoring of Dengue Patients
Perioperative Fluid Management
Management of Severe Dengue
Dengue fever Febrile phase 2-7 DAYS Convalescent phase 2-5 DAYS Longer in adults 1.
Fluids replacement Professor Magdy Amin RIAD Professor of Otolaryngology. Ain shames University Senior Lecturer in Otolaryngology University of Dundee.
Blood Transfusion in Acute Trauma
Chapter 32 Shock Copyright (c) The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Chapter 23 - IV Fluids and Electrolytes Seth Christian, MD MBA Tulane University Hospital and Clinic Seth Christian, MD MBA Tulane University Hospital.
Fluid Resuscitation of Burns PAEDIATRIC Towards Excellence in Care.
Pediatric Septic Shock
D NGUE WORKSHOP 2015 ID HSB OPD – CASE 3 ID HSB 2015.
E D NGUE WORKSHOP 2015 CHALLENGES IN THE MANAGEMENT OF DENGUE
Life Support in Haemorrhage and Fluid Loss H.Gee MD, FRCOG.
Fluid and Electrolytes
VII. Treatment. Outpatient Triage n No hemorrhagic manifestations and patient is well-hydrated: home treatment n Hemorrhagic manifestations or hydration.
In Taiwan Luke Huang & Jessica Leung.
General Surgery Mosul university- College of dentistry-oral & maxillofacial surgery department Dr. Ziad H. Delemi B.D.S, F.I.B.M.S (M.F.) Fluid Therapy.
CTVT pgs A&A pgs (Anesthetist). Indications for Fluid Administration Hypovolemia.
Fluid Management. The rule:  60% total body weight is water  40% of total body weight is intracellular fluids  20% of body weight is extracellular.
PRINCIPLES OF FLUIDS AND ELECTROLYTES
Post-op Note and Fluid Management By Yasmin Kusow Assia Zakani Huda Matbuli.
Fluid Balance. Body Fluid Spaces ECF: Interstitial fluid ICF 2/3 of body fluid ECF Vascular Space.
CASE 9 FLUID REPLACEMENT THERAPY Group B. A 54-year-old man is undergoing a laparotomy and colon resection for carcinoma. The anesthesiologist is attempting.
MUDr. Štefan Trenkler, PhD. I. KAIM UPJS LF a UNLP Košice Water balance, infusions Košice 2012.
Shock and its treatment Jozsef Stankovics Department of Paediatrics, Medical University of Pécs 2008.
Objectives  To understand the structured approach to circulation problems  To recognise and manage shock.
Blood Transfusions 1. Blood Administration Blood transfusion includes any of the following : whole blood packed RBC’s plasma platelets Purpose: 1.Increase.
Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.
Pediatric Sepsis Dr. S. Veroukis Pediatric Critical Care
Fluid Management and Transfusion Franklin L. Scamman, MD.
DENGUE FEVER Prof. Dr. Muhammad Ali Khan MBBS, DCH, MRCP (UK)
Fluid Balance.
Maintenance and Replacement Therapy
TRANSFUSION REACTIONS
Fluid Replacement Therapy
Fluid Therapy General Surgery Dr. Ziad H. Delemi
Fluid Balance Daniel Jones.
PRINCIPLES OF FLUID THERAPY
INTRAVENOUS FLUIDS Batool Luay Basyouni
Approach to fluid therapy
Plasma expanders Dept. of Pharmacology CIPS.
Presentation transcript:

2. Fluid Management in Dengue Hemorrhagic Fever Dengue Expert Advisory Group

Dengue Virus Infection Asymptomatic Symptomatic – Undifferentiated Febrile Illness – Dengue Fever – Dengue Hemorrhagic Fever  Non Shock  Shock

Dengue Hemorrhagic Fever Febrile Phase Critical phase characterized by plasma leak Convalescent Phase

Dengue “Leak” Fever Plasma leak during critical phase is the hall mark Leading to 3rd space losses – peritoneal cavity – pleural cavity Variable in magnitude and exact timing

Pathogenesis of leak Infection with a virulent dengue virus Presence of antibodies that enhance dengue virus infection (ADE) Intense immune activation

Pathogenesis Rapidly elevated cytokines (TNF-a, IL-2, IL-6, IL-8, IL-10, IL-12, and IFN-g) Malfunction of vascular endothelial cells Plasma leakage from intra to extravascular space

Pathogenesis In severe DHF the loss of plasma is critical Patient becomes hypovolaemic Signs of circulatory compromise Progress to shock, organ failure, death

Pathogenesis Cytokine Storm Self limited Ends after 48 hours

Clinical Implications Extravascular fluid loss at variable rate that has to be matched ml for ml Lasting 48 hours Resorption of fluid during convalescent phase

Key Points Manage critical phase with appropriate volume – Don’t under transfuse – Don’t over transfuse Meticulous monitoring during critical phase to match rate of fluid infusion with rate of leak

Monitoring Parameters Clinical – Pulse Rate – Blood and Pulse Pressure – Capillary Refill Time – Urinary Output Lab – Hematocrit

Fluid Management Critical Phase

Amount of Fluid? Based on weight Adults – If less than 50kg use actual weight – If more take weight as 50 kg Paediatrics – Current OR Ideal body weight whichever is lower

Ideal Body Weight Weight for height using a growth chart Weight for age Formulae in emergency

Growth Charts

Formulae <1 year : Age (in Months)+ 9/2 1-7 years : (Age x 2)+ 8 APLS : (Age in years + 4) x 2

Fluid Quota M + 5% = Maintenance + 5% of body weight Over 48 hours if patient presents in the beginning of critical phase (without shock) Over 24 hours for patients coming in shock

M + 5% - Adults Maintenance – 1st 10 kg – 1000 mls – 2nd 10 kg – 500 mls – Remaining 30kgs – 600 mls – Sum = 2100 mls 5% deficit – 50 x 50 = 2500 mls Total = 4600 mls

Child 22 kg Maintenance – 1000 + 500 + 40 = 1540 mls 5% Deficit – 50 x 22 = 1100 mls Total 2640 mls

Types of Fluid Crystalloids – 0.9% Saline – 5%Dextrose 0.9% Saline – 5% Dextrose ½ saline

Monitoring – Critical Phase Vital parameters - hourly Fluid balance chart - assess three hourly HCT - six hourly

Fluid Management in Dengue Shock Syndrome

Compensated Body compensates for fluid loss Tachycardia Pulse Pressure narrows Prolonged CRT Fall in urine output to 0.5 mls/kg/hr

Decompensated Pulse pressure narrows further leading to unrecordable pulse and BP Urine output falls less than 0.5 mls/kg/hour

Fluid Resuscitation Crystalloids – N Saline Colloids – Dextran 40 in N. Saline – 6% Starch All boluses part of fluid quota

Indications for Colloid Failure of crystalloid boluses to normalize pulse /BP Development of shock – with fluid overload – amount of fluid exceeding M + 5% deficit 10 ml/kg over 1 hour

Colloids Dextran may sometimes interfere with grouping and cross matching 3 doses of Dextran 40 during a 24 hour 5 doses of 6% Starch during 24 hour Remain in circulation for much longer

Refractory Shock - ABCS Blood – packed cells – whole blood Bicarbonate Glucose Calcium

Monitoring During Shock 15 minute monitoring of vital signs HCT immediately before and after each fluid bolus and then at least two to four hourly

Key Points – Managing DHF Recognizing the start of critical phase of DHF Predicting the rate of leak which may vary from patient to patient and within the same patient Matching the rate of infusion to rate of leak Being cognizant of the end of critical phase

Key Points – Managing DSS Meticulous monitoring Switching appropriately from crystalloids to colloids Recognizing need for blood transfusion